178 related articles for article (PubMed ID: 31502470)
1. Focused size selection of cell-free DNA samples for liquid biopsy applications that rely on next-generation sequencing.
Raymond CK
Biotechniques; 2019 Oct; 67(4):188-191. PubMed ID: 31502470
[TBL] [Abstract][Full Text] [Related]
2. Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA.
Shen SY; Burgener JM; Bratman SV; De Carvalho DD
Nat Protoc; 2019 Oct; 14(10):2749-2780. PubMed ID: 31471598
[TBL] [Abstract][Full Text] [Related]
3. UltraPrep is a scalable, cost-effective, bead-based method for purifying cell-free DNA.
Raymond CK; Raymond FC; Hill K
PLoS One; 2020; 15(6):e0231854. PubMed ID: 32479545
[TBL] [Abstract][Full Text] [Related]
4. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.
Bennett CW; Berchem G; Kim YJ; El-Khoury V
Oncotarget; 2016 Oct; 7(43):71013-71035. PubMed ID: 27589834
[TBL] [Abstract][Full Text] [Related]
5. Simple and cost-effective laboratory methods to evaluate and validate cell-free DNA isolation.
Mojtabanezhad Shariatpanahi A; Rokni P; Shahabi E; Varshoee Tabrizi F; Kerachian MA
BMC Res Notes; 2018 Oct; 11(1):757. PubMed ID: 30352614
[TBL] [Abstract][Full Text] [Related]
6. [Liquid Biopsy: Challenges and Possibilities Regarding Its Clinical Application.].
Furuta K
Rinsho Byori; 2016 May; 64(4):394-399. PubMed ID: 29182805
[TBL] [Abstract][Full Text] [Related]
7. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
8. Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA.
Chae YK; Davis AA; Carneiro BA; Chandra S; Mohindra N; Kalyan A; Kaplan J; Matsangou M; Pai S; Costa R; Jovanovic B; Cristofanilli M; Platanias LC; Giles FJ
Oncotarget; 2016 Oct; 7(40):65364-65373. PubMed ID: 27588476
[TBL] [Abstract][Full Text] [Related]
9. Urinary Nucleic Acid in Tumor: Bioinformatics Approaches.
Angeli D
Methods Mol Biol; 2021; 2292():95-104. PubMed ID: 33651354
[TBL] [Abstract][Full Text] [Related]
10. A high-throughput protocol for isolating cell-free circulating tumor DNA from peripheral blood.
Pandoh PK; Corbett RD; McDonald H; Alcaide M; Kirk H; Trinh E; Haile S; MacLeod T; Smailus D; Bilobram S; Mungall AJ; Ma Y; Moore RA; Coope R; Zhao Y; Jones SJ; Holt RA; Karsan A; Morin RD; Marra MA
Biotechniques; 2019 Feb; 66(2):85-92. PubMed ID: 30744412
[TBL] [Abstract][Full Text] [Related]
11. An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.
Mayo-de-Las-Casas C; Garzón Ibáñez M; Jordana-Ariza N; García-Peláez B; Balada-Bel A; Villatoro S; Malapelle U; Karachaliou N; Troncone G; Rosell R; Molina-Vila MA
Expert Rev Mol Diagn; 2018 Jan; 18(1):35-45. PubMed ID: 29172773
[TBL] [Abstract][Full Text] [Related]
12. Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas.
Hickmann AK; Frick M; Hadaschik D; Battke F; Bittl M; Ganslandt O; Biskup S; Döcker D
BMC Cancer; 2019 Mar; 19(1):192. PubMed ID: 30823914
[TBL] [Abstract][Full Text] [Related]
13. Microfluidic-based solid phase extraction of cell free DNA.
Campos CDM; Gamage SST; Jackson JM; Witek MA; Park DS; Murphy MC; Godwin AK; Soper SA
Lab Chip; 2018 Nov; 18(22):3459-3470. PubMed ID: 30339164
[TBL] [Abstract][Full Text] [Related]
14. Ultrasensitive Detection of Circulating Tumor DNA in Lymphoma via Targeted Hybridization Capture and Deep Sequencing of Barcoded Libraries.
Alcaide M; Rushton C; Morin RD
Methods Mol Biol; 2019; 1956():383-435. PubMed ID: 30779047
[TBL] [Abstract][Full Text] [Related]
15. Detection of mutational patterns in cell-free DNA of colorectal cancer by custom amplicon sequencing.
Herrmann S; Zhan T; Betge J; Rauscher B; Belle S; Gutting T; Schulte N; Jesenofsky R; Härtel N; Gaiser T; Hofheinz RD; Ebert MP; Boutros M
Mol Oncol; 2019 Aug; 13(8):1669-1683. PubMed ID: 31254442
[TBL] [Abstract][Full Text] [Related]
16. A nano-magnetic size selective cfDNA extraction platform for liquid biopsy with enhanced precision.
Liu Y; Cheng L; Wang G; Lv J; He Y; Shao PL; Hu R; Xiao H; Tang J; Niu D; Yang J; Tang Z; Xu Z; Liu Y; Li Y; Song K; Wu B; Zhang B
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 May; 1199():123236. PubMed ID: 35472714
[TBL] [Abstract][Full Text] [Related]
17. Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics.
Song P; Wu LR; Yan YH; Zhang JX; Chu T; Kwong LN; Patel AA; Zhang DY
Nat Biomed Eng; 2022 Mar; 6(3):232-245. PubMed ID: 35102279
[TBL] [Abstract][Full Text] [Related]
18. Digital Droplet PCR for Monitoring Tissue-Specific Cell Death Using DNA Methylation Patterns of Circulating Cell-Free DNA.
Shemer R; Magenheim J; Dor Y
Curr Protoc Mol Biol; 2019 Jun; 127(1):e90. PubMed ID: 31237424
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy for infectious diseases: a focus on microbial cell-free DNA sequencing.
Han D; Li R; Shi J; Tan P; Zhang R; Li J
Theranostics; 2020; 10(12):5501-5513. PubMed ID: 32373224
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer.
Liu X; Liu L; Ji Y; Li C; Wei T; Yang X; Zhang Y; Cai X; Gao Y; Xu W; Rao S; Jin D; Lou W; Qiu Z; Wang X
EBioMedicine; 2019 Mar; 41():345-356. PubMed ID: 30857943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]